OSIVAX – new member

12 June 2023
New member

OSIVAXOsivax is developing a new class of universal vaccines empowering both arms of the immune system. By combining its disruptive oligoDOMĀ® T-cell vaccines with traditional antibody-based vaccines, Osivax approach aims to provide universal protection against current and future strains of influenza along with existing and emerging coronavirus infections. Osivax is focused on providing proof-of-concept in these indications, with plans to apply its technology broadly to other infectious diseases.. To know more